Abstracts tagged "Hospital admissions"

Abstract Number: 0591 • ACR Convergence 2021
The Temporal Association Between Hospital Admissions, Disease-modifying Anti-rheumatic Drugs Usage and Direct Health Care Costs in Rheumatoid Arthritis Patients
Khalid Almutairi¹, Johannes Nossent¹, David Preen¹, Helen Keen² and Charles Inderjeeth³, ¹University of Western Australia, Perth, Australia, ²University of Western Australia, Daglish, Australia, ³University of Western Australia, Nedlands, Perth, Australia
Background/Purpose: Rheumatoid arthritis (RA) carries a substantial burden for patients and society in terms of morbidity, disability, and medical expenses. The Australian Pharmaceutical Benefits Scheme…
Abstract Number: 1552 • ACR Convergence 2021
Systemic Autoimmune Conditions and Hospital Admissions in Covid-19 Infection
Inés Perez - Sancristobal¹, Leticia Lopez Pedraza², María Paula Álvarez Hernández¹, Jose Ignacio Colomer³, Alfredo Madrid - Garcia², Benjamin Fernandez⁴, Cristina Martínez - Prada⁴, Luis Rodriguez Rodriguez⁵, Arkaitz Mucientes², Leticia Leon - Mateos² and Lydia Abasolo⁶, ¹Hospital Clínico San Carlos, Reumathology, Madrid, Spain, Madrid, Spain, ²Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Reumathology, Madrid, Spain, ³Fundación para la Investigación Biomedica, Reumathology, Madrid, Spain, ⁴Hospital Clínico San Carlos, Reumathology, Madrid, Madrid, Spain, ⁵Hospital Clinico San Carlos, Madrid, Spain, ⁶Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain
Background/Purpose: The COVID-19 pandemic continues worldwide and has had a strong impact on public health. From the beginning of the pandemic, efforts were intensified to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].